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Abstract
Background: To report three cases of congenital corneal opacity where intraocular pressure (IOP) readings were
high despite the use of multiple anti-glaucoma eye drops and normalized after corneal transplantation.
Case presentation: Three Korean infants presented with bilateral dense stromal opacification which had been
present since birth. IOPs measured by rebound tonometer were high despite administration of multiple anti-
glaucoma medications. One eye of each patient underwent penetrating keratoplasty (PK) because corneal opacity
impaired visual development. Immediately after PK, IOPs were normalized and maintained normal without
medication, whereas they remained high in the contralateral unoperated eye. On histology, stromal fibrosis was
observed in the removed corneal button, and molecular assays revealed increased levels of type 1 and 5 collagens.
Conclusion: The IOP measurement using the conventional applanation-based tonometry can be inaccurate in
congenital corneal opacity which is marked by corneal fibrosis. Therefore, IOP values should be interpreted with
caution in these patients, and the possibility of false-positive diagnosis of glaucoma considered.
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Background
Congenital corneal opacity and congenital glaucoma com-
monly coexist in pediatric patients with anterior segment
dysgenesis. The diagnosis of glaucoma in these patients is
difficult because corneal opacification obscures
visualization of intraocular structures such as angle and
optic disc. Moreover, the measurement of intraocular
pressure (IOP) using conventional applanation-based to-
nometry is inaccurate in the abnormal cornea [1].
Herein, we report three Korean pediatric patients with
congenital corneal opacity presenting as dense stromal
opacification. In the patients, IOP readings were high
despite the use of multiple anti-glaucoma eye drops. Im-
mediately after corneal transplantation, IOPs were nor-
malized and maintained within a normal range in the
absence of anti-glaucoma medication. Histologic and
molecular analysis showed high levels of collagen depos-
ition in the corneal stroma.
Case presentation
The study was approved by the Institutional Review
Board of Seoul National University Hospital.
Case 1
A 7-month-old girl was referred to our clinic for corneal
opacity and glaucoma that had been present in both eyes
since birth. She was born at full-term weighing 2.7 kg
and received a brief intensive care unit care due to tach-
ypnea. Otherwise, the infant was systemically healthy,
and all serological test results for TORCH (toxoplasmo-
sis, rubella, cytomegalovirus, and herpes simplex virus)
embryopathy were negative. Slit lamp examination
showed dense stromal opacity in the central cornea in
both eyes (Fig. 1a, b). The corneal diameter was 11
mm × 10.5 mm in both eyes, and ultrasound pachymetry
failed. Anterior chamber was formed, and partial aniridia
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: jooyounoh77@gmail.com; bonzoo1@snu.ac.kr
1Department of Ophthalmology, Seoul National University College of
Medicine, 103, Daehak-ro, Jongno-gu, Seoul 03080, South Korea
2Laboratory of Ocular Regenerative Medicine and Immunology, Biomedical
Research Institute, Seoul National University Hospital, 101, Daehak-ro,
Jongno-gu, Seoul 03080, South Korea
Kang et al. BMC Ophthalmology            (2020) 20:3 
https://doi.org/10.1186/s12886-019-1287-7
was observed. The fundus was invisible, but ultrasonog-
raphy showed no abnormality in the posterior segment.
IOP was 42.5 mmHg in the right eye and 45.1 mmHg in
the left as measured by a rebound tonometer (Icare®
PRO; Icare, Helsinki, Finland). Despite combined treat-
ment of 0.005% latanoprost (Xalatan®; Pfizer, New York,
NY) QD and 2% dorzolamide/0.5% timolol (Cosopt®;
MSD, Riom, France) BID, the IOP did not decrease in
both eyes. To correct corneal opacity, penetrating
keratoplasty (PK) was performed in the right eye. Histo-
logic examination of an excised corneal button revealed
stromal fibrosis (Fig. 1c). One day after PK, the IOP was
reduced to 18.8 mmHg in the right eye without adminis-
tration of any IOP-reducing agents (Fig. 1d), while it
remained high in the other eye. The IOP in the right eye
was maintained within normal range for 36 months of
follow-up without the use of anti-glaucoma medication.
Case 2
A 15-day-old boy visited our clinic because of bilateral
corneal opacity present at birth. He was born full-term
at 3.24 kg. At initial examination, dense central corneal
Fig. 1 Case 1. a, b Anterior segment photography of the right (a) and left (b) eyes taken at the initial visit to our clinic (7 months after birth). The
intraocular pressure (IOP) values measured by a rebound tonometer were 42.5 mmHg OD and 45.1 mmHg OS. c Hematoxylin-eosin staining of
the right cornea excised at the time of penetrating keratoplasty (PK). Scale bar, 200 μm. d Anterior segment photograph of the right eye 1 day
after PK. The IOP by a rebound tonometer was 18.8 mmHg OD
Fig. 2 Case 2. a, b Anterior segment photography of the right (a) and left eyes (b) 15 days after birth. The intraocular pressure (IOP) was 32.5
mmHg OD and 26.4 mmHg OS by rebound tonometer. c Anterior segment photograph of the left eye 2 days after penetrating keratoplasty (PK).
IOP was reduced to 21.0 mmHg OS. d Anterior segment photograph of the left eye 18months after surgery. The IOP was 17.5 mmHg without
anti-glaucoma medication OS
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opacity was observed in both eyes (Fig. 2a, b). The anter-
ior chamber was present, and iris was normal. No spe-
cific findings were seen in the retina or vitreous cavity
on ultrasonography. The corneal diameter was 12 mm ×
11.5 mm in the right eye and 11 mm × 10.5 mm in the
left. The corneal thickness was unmeasurable by ultra-
sonic pachymeter. The IOP was 32.5 mmHg in the right
eye and 26.4 mmHg in the left eye by Icare® rebound
tonometer. The patient started instillation of 0.005%
latanoprost (Xalatan®) QD and 1% brinzolamide/0.5%
timolol (Elazop®, Alcon, Fort Worth, TX) BID, and was
referred to a pediatrician for examination of associated
systemic anomalies. No systemic abnormality was de-
tected, and the TORCH screen results were negative.
Despite anti-glaucoma medications, IOP remained high
in both eyes, and corneal opacity was severe enough to
impair visual development. Hence, PK was performed in
the left eye at the age of 4 months. In the operation
room, IOP was 29.4 mmHg in the right eye and 30.5
mmHg in the left even after systemic administration of
mannitol and topical anti-glaucoma eye drop instillation.
Two days after surgery, the corneal graft was clear (Fig.
2c), and IOP dropped to 21.0 mmHg in the left eye in
the absence of any IOP-lowering treatment. At last
follow-up (post-operative 36 months), the graft was clear
(Fig. 2d), and IOP was 17.5 mmHg without using anti-
glaucoma eye drops. However, IOP in the unoperated
eye remained high (32.8 mmHg) even with Xalatan® QD
and Cosopt® BID.
We additionally analyzed the excised cornea for levels
of collagen type I, V, and lumican by real-time RT PCR
and compared with control corneas obtained from two
patients who underwent PK due to congenital hereditary
endothelial dystrophy (CHED). Results demonstrated
that the mRNA levels of type I and V collagens were
19.7 and 7.5 times higher in the patient than in the con-
trol (Table 1).
Case 3
A 3-month-old girl was referred to our clinic for con-
genital corneal opacity and increased IOP in both eyes.
According to the medical report, she was a full-term
baby and systemically healthy except for corneal opacity
at birth. Her IOPs were 32.0 and 31.0 mmHg in the right
and left eyes, respectively when measured 1 day after
birth, and therefore, she started treatment with Xalatan®
QD and Elazop® BID since 4 days after birth. TORCH
work-up revealed negative results. At first examination
in our clinic, total corneal opacity and complete aniridia
were found in both eyes (Fig. 3a, b). The corneal diam-
eter was 11mm × 10.5 mm and thickness uncheckable.
IOP was 38.1 mmHg in the right eye and 35.7 mmHg in
the left eye by a rebound tonometer (Icare® PRO). At 10
months of age, the patient underwent PK in the right
eye. Prior to surgery, mannitol was intravenously admin-
istered and Xalatan® and Elazop® eye drops instilled, but
the IOP was checked 31.5 mmHg. During surgery, the
lens was spontaneously delivered right after trephination
of the recipient cornea, and therefore, lens removal was
performed together with corneal transplantation. On the
next day, the IOP was reduced to 14.2 mmHg without
anti-glaucoma treatment (Fig. 3c), and the anti-
glaucoma medication was discontinued in the right eye
thereafter. Four months of surgery, the graft rejection
occurred, and the cornea was opacified with
vascularization (Fig. 3d). Nonetheless, the IOP in the
right eye was maintained within a range of normal
values without medication for 34 months of follow-up,
while it remained high (42.3 mmHg) in the left eye even
with medication.
Real-time RT PCR analysis of the excised cornea at
the time of surgery revealed that the mRNA levels of
collagen type I and V were 9.5 and 2.8 times higher, re-
spectively, compared to those in control corneas (Table
1).
Discussion and conclusions
The conventional methods for IOP measurement are
based on corneal applanation and measure the force re-
quired to flatten a constant area of the cornea. There-
fore, IOP measurement by applanation-based tonometry
largely depends on biomechanical properties of the cor-
nea, and tonometry artefacts can occur in abnormal cor-
neas [1]. For example, IOP reading can be artificially
high in the eye with high central corneal thickness [2].
Keratoconus, prior keratorefractive surgery, or corneal
cross-linking procedure can alter corneal hysteresis
(CH), leading to IOP mismeasurement [3–6]. Also, CH
can be affected by corneal fibrosis. For example, corneal
opacification occurred as a result of cicatrization and fi-
brotic changes in the anterior stroma in patients with
mucopolysaccharidosis (MPS) [7], and CH was reported
to be higher in MPS patients as assessed by Ocular Re-
sponse Analyzer [8]. High CH values overestimate IOP
[9]. Therefore, it is possible that corneal stromal fibrosis
Table 1 Real time RT-PCR analysis of the cornea for extracellular
matrix proteins
Collage type 1 Collagen type 5 Luimcan
Case 2 19.7a 7.5 1.19
Case 3 9.5 2.8 0.39
Control 1b 1 1 1
Control 2b 1.25 0.96 0.10
aData are presented as a fold change relative to control corneas
bControl corneas were obtained from patients with CHED at the time of
penetrating keratoplasty (PK). PK was performed at 4 years of age in control 1
and 10 months in control 2
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and the resultant high CH lead to higher IOP readings
by applanation tonometer than true IOP values.
The rebound tonometer, a recently developed hand-
held tonometer, is considered safe and suitable for a
pediatric population, because corneal application by a
rebound tonometer is fast and corneal anesthesia is not
required. In addition, it was reported that IOP values
measured by rebound tonometer in pediatric glaucoma
patients were similar to those by Goldmann applanation
tonometer [10, 11]. However, IOP measurements by re-
bound tonometer can be affected by central corneal
thickness and corneal biomechanical properties [12–14].
Despite high IOP readings as measured by rebound
tonometer (upto or over 30 mmHg), the corneal size was
normal (≤ 11 mm of diameter) and there were no symp-
toms of epiphora, photophobia and blepharospasm (the
classical triad of symptoms in congenital glaucoma) in
our patients. Moreover, administration of multiple anti-
glaucoma medications was not effective in reducing
IOPs. For these reasons, we suspected that the increased
IOP measurements in our patients might not be due to
congenital glaucoma but derived from thickened and
stiffened corneas, and performed PK to clear the visual
axis from dense opacity. Consequently, IOPs were im-
mediately normalized by corneal transplantation and
thereafter controlled without medication, whereas the
IOPs in the unoperated eye remained high with using
anti-glaucoma medication. The corneal opacity in our
cases was clinically dense central stromal opacification
in both eyes. Histologically, stromal fibrosis was ob-
served (case 1), and molecular assay revealed increased
levels of type 1 and 5 collagens which are the main
extracellular matrix components of the corneal stroma
(cases 2 and 3). Although we did not directly measure
CH in these patients, it is likely that corneal fibrosis
might increase corneal resistance to applanation, thereby
leading to overestimation of IOPs by rebound
tonometry.
In summary, our cases demonstrate that the conven-
tional IOP measurement method using transcorneal ap-
proach might be incorrect and inadequate in congenital
corneal opacity where CH is altered due to corneal fi-
brosis. In these patients, IOP values should be inter-
preted with caution, and the possibility of false-positive
diagnosis of glaucoma considered. Eventually, new tech-
nology for measuring IOP independently of corneal bio-
mechanical properties is needed for accurate IOP
measurement and glaucoma diagnosis.
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